Conference abstractPublished 27 Jun 2022

Next Frontier in Healthcares-Stem Cells and Cell therapies

Authors: Pradeep V. Mahajan

Journal of Anatomical Science and Research

Volume 5 · Issue 2 · Pages 1

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The concept of mesenchymal stem cells (MSC) being proposed as a medicinal signaling agent is based on the fact that cells are not single molecular agents. MSCs, which more appropriately may be called ‘Living Drug’ molecules, are adaptive agents capable of complex functions involving many bioactive factors. These multi-potent cells may be considered injury-specific drug stores that home to the site of injury and secrete considerable levels of immunomodulatory and trophic factors. MSCs reduce inflammation, modulate the immune system, as well as stimulate other cells to perform their functions effectively (paracrine properties). In addition, MSCs can function as regulated delivery vehicles and target specific molecules that act against cancerous cells. This could be an interesting avenue of research in cancer immunotherapy, to enhance the outcomes of dendritic and natural killer cell therapies.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. EuroSciCon does not store it.

Try:

More from this journal

The newest in Journal of Anatomical Science and Research.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Anatomical Science and Research
  • SubjectGenetics & Molecular Biology
  • SubjectNursing & Healthcare
  • BylineArticles whose byline prints “Pradeep V. Mahajan”